Chronic myeloid leukemia (CML) is a clonal hematopoietic stem cell disorder, characterized by the BCR-ABL1 fusion gene leading to an aberrant chimeric tyrosine kinase (TK). Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.